Europe — EMA

Novolizer (Budesonide)

Budesonide, the active ingredient in Novolizer, is a glucocorticoid presented as a inhaled corticosteroid for maintenance treatment of asthma in adults and adolescents.

Budesonide

Request sourcing

Pack/s

What is Budesonide?

Budesonide, the active ingredient in Novolizer, is a glucocorticoid presented as a inhaled corticosteroid for maintenance treatment of asthma in adults and adolescents. It reduces airway inflammation and improves breathing control.

GNH USA supplies Novolizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Budesonide used for?

Novolizer is an inhaled corticosteroid that acts on the inflammatory pathway of the respiratory tract. - Asthma: Improves symptom control and reduces the frequency of exacerbations. - Chronic Obstructive Pulmonary Disease (COPD): Helps ... - ...

What are the side effects of Budesonide?

This ...

What precautions apply to Budesonide?

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →